A meta-analysis of 15 randomized controlled trials found that hyperbaric oxygen therapy produced measurable improvements in motor function, sensory recovery, and daily living activities in people with incomplete traumatic spinal cord injury, but methodological limitations mean these findings warrant cautious interpretation.
Researchers conducting this systematic review and meta-analysis searched five major databases through June 2025 and identified 15 randomized controlled trials evaluating hyperbaric oxygen as an adjunctive treatment for incomplete traumatic spinal cord injury. The pooled analysis revealed consistent improvements across multiple standardized measures of neurological recovery.
The most substantial gains appeared in motor function, measured using the American Spinal Injury Association (ASIA) motor score. Participants receiving hyperbaric oxygen showed an average improvement of 10.30 points compared to control groups, with the 95% confidence interval ranging from 7.70 to 12.90 points. This represents movement-related recovery following spinal trauma. Sensory function also improved significantly. The total ASIA sensory score increased by 29.29 points (95% CI: 18.82-39.75), while light touch sensation improved by 9.84 points (95% CI: 6.15-13.53) and pinprick sensation by 8.75 points (95% CI: 4.40-13.11). These measures assess the nervous system's ability to detect and process tactile and pain stimuli.
Beyond neurological markers, functional independence in daily activities showed clinically meaningful gains. The Barthel Index, which measures capacity for self-care and mobility, improved by 16.60 points (95% CI: 10.51-22.68). The Functional Independence Measure, a broader assessment of independence in activities of daily living, increased by 17.41 points (95% CI: 10.83-23.98). These functional improvements suggest that neurological gains translated into practical increases in autonomy.
However, the authors explicitly cautioned that their conclusions require careful interpretation. They identified significant methodological limitations across the included trials and noted potential publication bias, meaning studies with positive results may have been more likely to appear in literature searches than those with null findings. The mechanism by which hyperbaric oxygen might promote spinal cord recovery remains unclear, and variability in treatment protocols, timing post-injury, and outcome measurement across studies may have affected result validity.
If you or someone you know has experienced an incomplete traumatic spinal cord injury, this research suggests hyperbaric oxygen may offer measurable neurological and functional benefits when used alongside conventional rehabilitation. The improvements documented across multiple independent outcome measures are noteworthy, but they do not constitute definitive proof of efficacy.
Several practical considerations apply:
Access and timing matter. Hyperbaric oxygen therapy requires specialized facilities and repeated sessions (typically 30-40 sessions over weeks). The timing relative to injury, duration of treatment, and whether it works best for recent versus chronic injuries remain incompletely understood from the available evidence.
Expect incremental gains, not dramatic recovery. While the numerical improvements are statistically significant and the confidence intervals exclude zero, average gains of 10 points on motor scores or 16-17 points on functional measures represent meaningful but modest recovery in the context of spinal injury.
This should complement, not replace, standard care. All trials included hyperbaric oxygen as an adjunctive treatment alongside conventional rehabilitation, medical management, and physical therapy. The studies do not establish hyperbaric oxygen as a standalone intervention.
Discuss with your rehabilitation team whether you might be a candidate. Spinal cord injuries vary enormously in severity, location, and individual physiology. Your medical team can assess whether hyperbaric oxygen therapy fits your specific clinical picture and rehabilitation trajectory.
Be alert to quality concerns in any trial or facility offering this treatment. The authors identified methodological weaknesses in the reviewed studies, including potential bias. High-quality, large-scale, multi-center trials remain needed to establish definitive efficacy.
| Attribute | Details |
|---|---|
| Study Type | Systematic review and meta-analysis |
| Number of Trials Reviewed | 15 randomized controlled trials |
| Condition | Incomplete traumatic spinal cord injury |
| Intervention | Hyperbaric oxygen therapy (adjunctive) |
| Primary Outcomes | ASIA motor score, ASIA sensory score (total, light touch, pinprick) |
| Secondary Outcomes | Barthel Index, Functional Independence Measure |
| Databases Searched | PubMed, Embase, Cochrane Library, Web of Science, major Chinese databases |
| Search Period | Through June 2025 |
| Journal | Medical Gas Research |
| PubMed ID | 42734451 |
| Evidence Tier | B tier (meta-analysis with noted limitations) |
Hyperbaric oxygen for the treatment of traumatic incomplete spinal cord injury: a systematic review and meta-analysis of randomized controlled trials. Medical Gas Research. PubMed: 42734451
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.